Risk factors for intrahepatic cholangiocarcinoma:A case-control study in China

被引:34
作者
Yan-Ming Zhou
机构
关键词
Intrahepatic cholangiocarcinoma; Hepatitis B virus; Hepatitis C virus; Risk factors;
D O I
暂无
中图分类号
R735.8 [胆囊、胆道肿瘤];
学科分类号
100214 ;
摘要
AIM: To carry out a hospital-based case-control study to investigate risk factors for intrahepatic cholangiocarcinoma (ICC) in China. METHODS: A total of 312 ICC cases and 438 matched controls were included in the study. The presence of diabetes mellitus,hypertention,hepatolithiasis,primary sclerosing cholangitis,liver fluke infection (Clonorchis sinensis ),was investigated through clinical records. Blood from all participants was tested for hepatitis B surface antigen (HBsAg) and anti-HCV antibodies. Odds ratios (OR) and 95% confi dence intervals (95% CI) were estimated using conditional logistic regression. RESULTS: Compared with controls,ICC patients had a higher prevalence of HBsAg seropositivity (48.4% vs 9.6%,P < 0.000),and hepatolithiasis (5.4% vs 1.1%,P = 0.001). By multivariate analysis,the signif icant risk factors for development of ICC were HBsAg seropositivity (adjusted OR,8.876,95% CI,5.973-13.192),and hepatolithiasis (adjusted OR,5.765,95% CI,1.972-16.851). The prevalence of anti-HCV seropositivity,diabetes mellitus,hypertention,cigarette smoking,and alcohol consumption were not significantly different between cases and controls. CONCLUSION: These findings suggest that HBV infection and hepatolithiasis are strong risk factors for development of ICC in China.
引用
收藏
页码:632 / 635
页数:4
相关论文
共 12 条
[1]  
HBV induced carcinogenesis[J] . Delphine Cougot,Christine Neuveut,Marie Annick Buendia.Journal of Clinical Virology . 2005
[2]  
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study[J] . Yasser H. Shaib,Hashem B. El-Serag,Jessica A. Davila,Robert Morgan,Katherine A. McGlynn.Gastroenterology . 2005 (3)
[3]   Frequent p16INK4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis [J].
Ishikawa, A ;
Sasaki, M ;
Sato, Y ;
Ohira, S ;
Chen, IF ;
Huang, SF ;
Oda, K ;
Nimura, Y ;
Nakanuma, Y .
HUMAN PATHOLOGY, 2004, 35 (12) :1505-1514
[4]   The epidemiology of cholangiocarcinoma [J].
Shaib, Y ;
El-Serag, HB .
SEMINARS IN LIVER DISEASE, 2004, 24 (02) :115-125
[5]   Prostaglandin E Receptors in Bile Ducts of Hepatolithiasis Patients and the Pathobiological Significance for Cholangitis [J].
Shoda, Junichi ;
Ueda, Tetsuya ;
Kawamoto, Toru ;
Todoroki, Takesi ;
Asano, Toru ;
Sugimoto, Yukihiko ;
Ichikawa, Atsushi ;
Maruyama, Takayuki ;
Nimura, Yuji ;
Tanaka, Naomi .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (04) :285-296
[6]   ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions [J].
Endo, K ;
Yoon, BI ;
Pairojkul, C ;
Demetris, AJ ;
Sirica, AE .
HEPATOLOGY, 2002, 36 (02) :439-450
[7]  
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy[J] . Francesco Donato,Umberto Gelatti,Alessandro Tagger,Maurizio Favret,Maria Lisa Ribero,Francesco Callea,Claudia Martelli,Antonella Savio,Paola Trevisi,Giuseppe Nardi.Cancer Causes and Control . 2001 (10)
[8]  
Precancerous lesions of intrahepatic cholangiocarcinoma[J] . Tomonori Shimonishi,Motoko Sasaki,Yasuni Nakanuma.Journal of Hepato-Biliary-Pancreatic Surgery . 2000 (6)
[9]   Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis [J].
Terada, T ;
Nakanuma, Y ;
Sirica, AE .
HUMAN PATHOLOGY, 1998, 29 (02) :175-180
[10]  
Demonstration of duck hepatitis B virus in bile duct epithelial cells: Implications for pathogenesis and persistent infection[J] . AJ Nicoll,PW Angus,ST Chou,CA Luscombe,RA Smallwood,SA Locarnini.Hepatology . 1997 (2)